Pharmacokinetic drug-drug interactions with methotrexate in oncology.

Pharmacokinetic drug-drug interactions with methotrexate in oncology.

Item
http://www.wikidata.org/entity/Q37960131
Glucarpidase to combat toxic levels of methotrexate in patientsUrinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.Personalizing chemotherapy dosing using pharmacological methods.Methotrexate-induced pancytopenia: a case series of 46 patients.Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population.Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic.
P2860

Pharmacokinetic drug-drug interactions with methotrexate in oncology.

Item
http://www.wikidata.org/entity/Q37960131
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@en
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@nl
type
label
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@en
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@nl
prefLabel
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@en
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Pharmacokinetic drug-drug interactions with methotrexate in oncology.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698